Undisclosed safety data at issue as weedkiller maker Syngenta faces US Parkinson's lawsuits
Syngenta denies withholding relevant data from the US Environmental Protection Agency as the weedkiller paraquat remains on the US market despite bans in dozens of other countries.
Written by EGazette’s AI. The facts are drawn from cited sources; the analysis is the AI’s own.
The maker of the weedkiller paraquat, Syngenta, is facing lawsuits in the United States linked to Parkinson's disease, amid claims that undisclosed safety data was kept from regulators even as the chemical has been banned in dozens of countries around the world.
Syngenta has denied withholding relevant data from the US Environmental Protection Agency. Paraquat remains available on the US market, even as evidence connecting the chemical to Parkinson's disease has led a growing number of countries to ban its use.
Sweden was among the first to raise concerns, calling for a ban on paraquat in 2004, more than two decades ago. Since then, dozens of other countries have followed with bans of their own, citing mounting evidence of links between the weedkiller and the neurodegenerative disease.
Despite this global trend, paraquat has continued to be sold and used in the United States, where it remains registered for agricultural use. The lawsuits against Syngenta centre on claims that the company held back safety information relevant to the EPA's assessment of the chemical's risks.
The case adds to a broader pattern of scrutiny facing agrochemical companies over their handling of safety data and the transparency of information shared with regulators. Syngenta has maintained that it has acted appropriately in its dealings with the EPA, and the litigation remains ongoing.
Sources
- Revealed: the undisclosed safety data emerging as weedkiller maker faces Parkinson’s lawsuits in US — The Guardian — Business
EGazette summarizes reporting from multiple sources; follow the links for the originals.
Comments
Loading comments…
Related articles
Two Indian Nationals Charged With Smuggling Counterfeit Ozempic From China, DOJ Says
The Justice Department announced criminal charges against two Indian nationals accused of smuggling counterfeit versions of the weight-loss drug Ozempic from China into Florida.
Soho House Venue Under Investigation Over Food Safety Complaint
Hackney Council is investigating a Soho House members' club venue after a former chef raised food safety concerns with local authorities.
Pakistan and Gavi hold talks on vaccine allocation and procurement
Officials discussed the country's vaccine needs, future allocation under Gavi's next planning period, and procurement of the Hexa vaccine.
Pakistan reviews HIV and Hepatitis C prevention measures at technical meeting
The fourth Technical Working Group session examined infection control and safe healthcare practices at the national health ministry.

Report: Wild top-pair D-man Faber has surgery on fractured skull
A report from ESPN sets out the main available details, with claims kept attributed to their sources.
Islamabad Health Regulator Assesses Advance International Hospital for Licensing
The Islamabad Healthcare Regulatory Authority conducted a licensing assessment of a private hospital as part of its ongoing evaluation process.